Siham Imani
CIK: 0001965525
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ASND
Ascendis Pharma A/S
Director
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About IMANI SIHAM
IMANI SIHAM (SEC CIK 0001965525) files insider reports with the SEC as Director of Ascendis Pharma A/S (ASND).
Signal8 holds 1 ownership filing by IMANI SIHAM, a Form 3, filed on Mar 18, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on IMANI SIHAM's filings is in HELLERUP.
Other insiders filing for Ascendis Pharma A/S (ASND)
- BIENAIME JEAN JACQUES, Director
- Bodenhoff Mads, SVP & PAO
- HOLTUG LARS, Director
- SMITH SCOTT THOMAS, EVP & Chief Financial Officer
- JENSEN FLEMMING STEEN
- Fairey William, Director